Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Pioglitazone

Pioglitazone (U 72107) is an orally active and selective PPARγ (peroxisome proliferator-activated receptor) agonist with high affinity binding to the PPARγ ligand-binding domain with EC50 of 0.93 and 0.99 μM for human and mouse PPARγ, respectively. Pioglitazone can be used in diabetes research[2][3][4].

Product Specifications

CAS Number

[111025-46-8]

Product Name Alternative

U 72107

UNSPSC

12352005

Hazard Statement

H302, H312, H332, H350, H360

Target

Ferroptosis; PPAR

Type

Reference compound

Related Pathways

Apoptosis; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor

Applications

Cancer-Kinase/protease

Field of Research

Metabolic Disease; Cancer

Assay Protocol

https://www.medchemexpress.com/pioglitazone.html

Concentration

10mM

Purity

99.89

Solubility

DMSO : 25 mg/mL (ultrasonic; warming; heat to 60°C)

Smiles

O=C(N1)SC(CC2=CC=C(OCCC3=NC=C(CC)C=C3)C=C2)C1=O

Molecular Formula

C19H20N2O3S

Molecular Weight

356.44

Precautions

H302, H312, H332, H350, H360

References & Citations

[1]Kuwabara K, et al. A novel selective peroxisome proliferator-activated receptor alpha agonist, 2-methyl-c-5-[4-[5-methyl-2- (4-methylphenyl) -4-oxazolyl]butyl]-1,3-dioxane-r-2-carboxylic acid (NS-220), potently decreases plasma triglyceride and glucose leve|[2]Puddu A, et al. Pioglitazone attenuates the detrimental effects of advanced glycation end-products in the pancreatic beta cell line HIT-T15. Regul Pept. 2012 Aug 20;177 (1-3) :79-84.|[3]Kubota N, et al. Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways. J Biol Chem. 2006 Mar 31;281 (13) :8748-55.|[4]Elrashidy RA, et al. Pioglitazone attenuates cardiac fibrosis and hypertrophy in a rat model of diabetic nephropathy. J Cardiovasc Pharmacol Ther. 2012 Sep;17 (3) :324-33.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

Launched

Isoform

PPARα; PPARβ/δ; PPARγ

Citation 01

Acta Pharmacol Sin. 2021 Jan;42 (1) :160-170.|Adv Sci (Weinh) . 2024 Dec 25:e2407134.|Adv Sci (Weinh) . 2024 Nov;11 (44) :e2401931.|Adv Sci (Weinh) . 2025 Nov 11:e08957.|Am J Chin Med. 2025;53 (1) :251-283.|Am J Physiol Heart Circ Physiol. 2021 Jun 1;320 (6) :H2222-H2239.|Am J Physiol Renal Physiol. 2019 Jul 1;317 (1) :F137-F151.|Biochem Eng J. 2021, 108104.|Biochem Pharmacol. 2025 Oct:240:117120.|Biol Proced Online. 2025 Jun 16;27 (1) :21.|BMC Complement Med Ther. 2022 Jul 1;22 (1) :176.|Br J Pharmacol. 2021 Jun;178 (11) :2305-2323.|Cancer Res. 2022 Apr 15;82 (8) :1503-1517.|Cell Metab. 2021 Mar 2;33 (3) :581-597.e9.|Cell Stem Cell. 2022 Sep 1;29 (9) :1366-1381.e9.|Eur J Pharmacol. 2025 Sep 15:1003:177943.|Food Chem Toxicol. 2021 Jun:152:112183.|Gut Microbes. 2022 Jan-Dec;14 (1) :2139978.|Heliyon. 2023 Apr 1;9 (4) :e15146.|Immunology. 2023 Jul;169 (3) :271-291.|Immunopharmacol Immunotoxicol. 2021 Dec;43 (6) :704-712.|J Adv Res. 2025 Aug:74:429-442.|J Ethnopharmacol. 2024 Nov 29:340:119128.|J Steroid Biochem Mol Biol. 2023 May:229:106265.|Med Sci Monit. 2019 Nov 13;25:8544-8553.|Nat Commun. 2025 Sep 10;16 (1) :8215.|Nutr Metab. 2019 Mar 5:16:17.|Oxid Med Cell Longev. 2022 Dec 5:2022:2226168.|Res Sq. 2024 Jul 12.|Research Square Preprint. 2021 Mar.|Sci China Chem. 2025 Jun 30.|SSRN. 2023 May 30.|SSRN. 2025 Jul 8.|Tunku Abdul Rahman University. 2024 Mar 11.|Inflammation. 2020 Apr;43 (2) :568-578.|Int J Oncol. 2018 Aug;53 (2) :551-566.|J Diabetes Res. 2019 Feb 3:2019:5245063.|Mol Med Rep. 2024 Nov;30 (5) :209.|Mol Med Rep. 2019 Jan;19 (1) :400-406.

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Rabbit Polyclonal IGFL4 Antibody

NBP2-14603 0.1 mL

Rabbit Polyclonal IGFL4 Antibody

Ask

Lentiviral mouse Actn3 shRNA (UAS) - Lentiviral mouse Actn3 shRNA (UAS, GFP) (100)

GTR15187581 1 Vial

Lentiviral mouse Actn3 shRNA (UAS) - Lentiviral mouse Actn3 shRNA (UAS, GFP) (100)

Ask

PARP1, phosphorylated (T373) (PARP1, ADPRT, PPOL, Poly [ADP-ribose] polymerase 1, ADP-ribosyltransferase diphtheria toxin-like 1, NAD(+) ADP-ribosyltransferase 1, Poly[ADP-ribose] synthase 1)

MBS645552-01 0.2 mL

PARP1, phosphorylated (T373) (PARP1, ADPRT, PPOL, Poly [ADP-ribose] polymerase 1, ADP-ribosyltransferase diphtheria toxin-like 1, NAD(+) ADP-ribosyltransferase 1, Poly[ADP-ribose] synthase 1)

Ask

PARP1, phosphorylated (T373) (PARP1, ADPRT, PPOL, Poly [ADP-ribose] polymerase 1, ADP-ribosyltransferase diphtheria toxin-like 1, NAD(+) ADP-ribosyltransferase 1, Poly[ADP-ribose] synthase 1)

MBS645552-02 5x 0.2 mL

PARP1, phosphorylated (T373) (PARP1, ADPRT, PPOL, Poly [ADP-ribose] polymerase 1, ADP-ribosyltransferase diphtheria toxin-like 1, NAD(+) ADP-ribosyltransferase 1, Poly[ADP-ribose] synthase 1)

Ask

P-Nitrophenyl 2,6-Di-O-benzoyl-a-D-galactopyranoside

N2594-06D 25 mg

P-Nitrophenyl 2,6-Di-O-benzoyl-a-D-galactopyranoside

Ask